Refractory Multiple Myeloma (RRMM)

Oncology·MeSH: Multiple Myeloma

21 drugs in development·9 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(8)

Drug	Company
bb2121	CELGENE CORP /DE/ (CELG) Analyze with AI →
bms-986393	Juno Therapeutics, Inc. (JUNO) Analyze with AI →
Carfilzomib	BRISTOL MYERS SQUIBB CO (BMY) Analyze with AI →
daratumumab	Juno Therapeutics, Inc. (JUNO) Analyze with AI →
Daratumumab	BRISTOL MYERS SQUIBB CO (BMY) Analyze with AI →
elotuzumab	REGENERON PHARMACEUTICALS, INC. (REGN) Analyze with AI →
Fludarabine	BRISTOL MYERS SQUIBB CO (BMY) Analyze with AI →
Pomalidomide	BRISTOL MYERS SQUIBB CO (BMY) Analyze with AI →

Phase 2(1)

Drug	Company
iberdomide	CELGENE CORP /DE/ (CELG) Analyze with AI →

Phase 1(3)

Drug	Company
ACLX-001	Arcellx, Inc. (ACLX) Analyze with AI →
linvoseltamab	REGENERON PHARMACEUTICALS, INC. (REGN) Analyze with AI →
sti-1492	Sorrento Therapeutics, Inc. (SRNE) Analyze with AI →

Unknown(1)

Drug	Company
non intervention	PFIZER INC (PFE) Analyze with AI →

Phase 1/Phase 2(5)

Drug	Company
daratumumab	GENMAB A/S (GNMSF) Analyze with AI →
daratumumab	Genmab A/S (GMAB) Analyze with AI →
gen3014	Genmab A/S (GMAB) Analyze with AI →
gen3014	GENMAB A/S (GNMSF) Analyze with AI →
regn17372+linvoseltamab	REGENERON PHARMACEUTICALS, INC. (REGN) Analyze with AI →

Phase 2/Phase 3(1)

Drug	Company
daratumumab	REGENERON PHARMACEUTICALS, INC. (REGN) Analyze with AI →

Phase 4(2)

Drug	Company
BMS-986393	BRISTOL MYERS SQUIBB CO (BMY) Analyze with AI →
tocilizumab	REGENERON PHARMACEUTICALS, INC. (REGN) Analyze with AI →

BioSniper tracks 21 drugs in development for Refractory Multiple Myeloma (RRMM) across 9 companies.

There are 1 clinical trial targeting Refractory Multiple Myeloma (RRMM) tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.